Bio-Connect
Product image
Product image
Product image

InVivoMAb anti-mouse VEGFR-2

Research Use Only
BE0060
Bio X Cell
ApplicationsWestern Blot, Neutralisation/Blocking
Product group Antibodies
ReactivityMouse
Price on request
When logged in and you are part of an academic or non-profit organisation your discount will be shown.
Packing Size
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Bio X Cell
  • Product Name
    InVivoMAb anti-mouse VEGFR-2
  • Delivery Days Customer
    7
  • Applications
    Western Blot, Neutralisation/Blocking
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    DC101
  • Concentration
    4-11 mg/ml
  • Host
    Rat
  • Isotype
    IgG1
  • Scientific Description
    The DC101 monoclonal antibody reacts with mouse VEGFR-2 (vascular endothelial growth factor receptor 2) also known as CD309, KDR, and Flk-1. VEGFR-2 is a member of the tyrosine protein kinase family. Upon binding to its ligand VEGF, VEGFR-2 pays key roles in vascular development and permeability. VEGFR-2 is expressed on endothelial cells at high levels in adult heart, lung, kidney, brain, and skeletal muscle as well as other tissues at lower levels. The DC101 antibody has been shown to inhibit VEGFR-2 signaling in vivo.
  • Reactivity
    Mouse
  • Storage Instruction
    2°C to 8°C
  • UNSPSC
    12352203

References

  • VEGF-Mediated Induction of PRD1-BF1/Blimp1 Expression Sensitizes Tumor Vasculature to Oncolytic Virus Infection. Arulanandam R et al., 2015 Aug 10, Cancer Cell
    Read more
  • Inhibition of vascular endothelial growth factor A and hypoxia-inducible factor 1alpha maximizes the effects of radiation in sarcoma mouse models through destruction of tumor vasculature. Lee HJ et al., 2015 Mar 1, Int J Radiat Oncol Biol Phys
    Read more
  • Distinct functions of epidermal and myeloid-derived VEGF-A in skin tumorigenesis mediated by HPV8. Ding X et al., 2015 Jan 15, Cancer Res
    Read more
  • Schlemms canal is a unique vessel with a combination of blood vascular and lymphatic phenotypes that forms by a novel developmental process. Kizhatil K et al., 2014 Jul, PLoS Biol
    Read more
  • Contrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtype. Larrayoz M et al., 2014 Apr, EMBO Mol Med
    Read more
  • Inhibition of VEGFR-2 reverses type 1 diabetes in NOD mice by abrogating insulitis and restoring islet function. Villalta SA et al., 2013 Aug, Diabetes
    Read more
  • Junctional adhesion molecule-A regulates vascular endothelial growth factor receptor-2 signaling-dependent mouse corneal wound healing. Chatterjee S et al., 2013, PLoS One
    Read more
  • Overcoming evasive resistance from vascular endothelial growth factor a inhibition in sarcomas by genetic or pharmacologic targeting of hypoxia-inducible factor 1alpha. Kim YJ et al., 2013 Jan 1, Int J Cancer
    Read more
  • Global lymphoid tissue remodeling during a viral infection is orchestrated by a B cell-lymphotoxin-dependent pathway. Kumar V et al., 2010 Jun 10, Blood
    Read more
  • Biomechanical regulation of blood vessel growth during tissue vascularization. Kilarski WW et al., 2009 Jun, Nat Med
    Read more

Related products

Product image
Product group Antibodies
References
Bio X Cell
ApplicationsWestern Blot, Neutralisation/Blocking
ReactivityMouse
  • SizePrice
More sizes
Product image
Product group Chemicals
Bio X Cell
  • SizePrice
Product image
Product group Antibodies
References
Bio X Cell
  • SizePrice
More sizes